文献速递脊柱关节炎

非放射学轴性脊柱关节炎无初始炎症证据者随时间可出现客观炎症

Non-radiographic axial spondyloarthritis patients without initial evidence of inflammation may develop objective inflammation over time.
PubMed 文献 · Rheumatology (Oxford) · 2017-01-01

该研究为ABILITY-1随机双盲试验的事后分析,评估非放射学轴性脊柱关节炎(nr-axSpA)患者客观炎症随时间的变化。94例安慰剂组患者中,基线时29例(30.9%)MRI正常、57例(60.6%)CRP正常、20例(21.3%)两者均正常;12周安慰剂后,部分患者出现MRI炎症(9/29,31.0%)、CRP升高(14/57,24.6%)或任一客观炎症(10/20,50.0%)。结论提示临床活动但初始无客观炎症证据者后续复测可能获益。

要点

  • nr-axSpA患者基线无MRI炎症或CRP正常者,12周后部分出现客观炎症。
  • 基线MRI和CRP均正常者中,50.0%在12周内出现MRI炎症和/或CRP升高。
  • 临床活动但初始无客观炎症证据者,建议后续复测炎症以指导治疗。

核心结论

  • 临床活动但初始缺乏客观炎症证据的nr-axSpA患者,随后可能出现MRI炎症或CRP升高,复测有助于指导治疗。

研究设计与样本

  • 随机双盲ABILITY-1研究(NCT00939003)的事后分析,nr-axSpA患者随机接受阿达木单抗40mg每两周一次或安慰剂12周,基线及第12周行MRI,每4周测CRP。

主要发现

  • 94例安慰剂组患者中,29例(30.9%)基线SIJ和脊柱MRI正常,57例(60.6%)CRP正常,20例(21.3%)MRI和CRP均正常。
  • 12周安慰剂后,9/29(31.0%)出现MRI炎症,14/57(24.6%)出现CRP升高,10/20(50.0%)出现MRI阳性和/或CRP升高。

关键数值与推荐

  • 基线MRI正常者中31.0%在12周出现MRI炎症;基线CRP正常者中24.6%出现CRP升高;两者均正常者中50.0%出现任一客观炎症。

临床怎么用

  • 对临床活动但初始MRI和CRP无炎症证据的nr-axSpA患者,可考虑后续复测MRI和CRP以发现客观炎症并指导治疗决策。

局限性

  • 本文为安慰剂组的事后分析,样本量有限,未报告统计比较或置信区间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: In patients with active axial spondyloarthritis (axSpA), inflammation in the SIJ or spine on MRI, an elevated CRP level or both are considered useful objective assessments for disease activity and initiation of TNF antagonists. The aim of this post hoc analysis of the randomized, double-blind ABILITY-1 study (NCT00939003) was to assess changes in objective inflammation over time. METHODS: Patients with non-radiographic axSpA (nr-axSpA) were randomized to receive adalimumab 40 mg every other week or placebo for 12 weeks in ABILITY-1. MRIs were performed at baseline and week 12; CRP was measured every 4 weeks. RESULTS: Of 94 placebo-treated ABILITY-1 patients, 29 (30.9%) had a normal MRI of the SIJs and spine, 57 (60.6%) had normal CRP and 20 (21.3%) had a normal MRI of the SIJs and spine and a normal CRP at baseline. After 12 weeks of placebo, 9/29 (31.0%) patients subsequently developed inflammation on MRI, 14/57 (24.6%) patients developed elevated CRP and 10/20 (50.0%) patients developed a positive MRI and/or elevated CRP through week 12. CONCLUSIONS: Patients who have clinically active disease but who lack objective evidence of inflammation initially may benefit from subsequent retesting for inflammation to guide treatment.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Baraliakos X, Sieper J, Chen S, et al. Non-radiographic axial spondyloarthritis patients without initial evidence of inflammation may develop objective inflammation over time. Rheumatology (Oxford). 2017. PMID: 28387855. doi:10.1093/rheumatology/kex081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。